Features January 2013 Issue

Diabetes Drugs Examined for Benefits, Risks to Heart Health

Metformin may have advantages over other commonly used diabetes medications, according to recent research.

In a recent study comparing the effectiveness of sulfonylureas and metformin as first-line treatments of diabetes, metformin was associated with more positive outcomes. The study, published recently in the Annals of Internal Medicine, found that sulfonylureas were associated with a 21 percent increased risk for acute myocardial infarction (heart attack), stroke or death compared to metformin.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.